A 52-year-old man suffered from chest tightness and dyspnea on exertion for two years. Because progressive symptoms failed to respond to medical treatment, the patient was admitted for heart transplantation evaluation. The donor heart had to be resuscitated, and its viability as an orthotopic transplant was unclear.
A 52-year-old man suffered from chest tightness and dyspnea on exertion for two years. Because progressive symptoms failed to respond to medical treatment, the patient was admitted for heart transplantation evaluation. The donor heart had to be resuscitated, and its viability as an orthotopic transplant was unclear.
Heterotopic heart transplant with arrhythmic heart rates.
In April 2001, a 48-year-old head injury donor with good cardiac function passed the brain-death examination. During transport of the donor to the Far Eastern Memorial Hospital, cardiac arrest occurred.
Cardiopulmonary resuscitation was performed immediately in the ambulance. When the donor arrived at the hospital, his blood pressure was 60/30 mm Hg, and his heart rate was 36 bpm. An immediate sternotomy revealed that the heart was already arrested, distended, and cyanotic. The donor was soon put on cardiopulmonary bypass. After that, the heart started to beat again and could maintain a stable hemodynamic status even when weaned off CPB. Since the suitability of the resuscitated heart as an orthotopic heart transplant was unclear, the hospital decided to do a heterotopic heart transplantation. Five years after successful surgery, the recipient is in good condition.
The left anterior descending coronary artery of the transplanted heart was successfully reconnected to the aorta. A 6-mm-diameter Gore-Tex graft was inserted between the aorta and the LAD. Both hearts are functional but show different heart rates and rhythms.
A. Maximum intensity projection image shows coronary arteries of native heart (arrow heads) and right coronary artery of transplanted heart (arrow).
B. Volume-rendered image shows heterotopic transplanted heart on patient's right side and native heart on left.
Case provided by Dr. Shu-Hsun Chu, Cardiovascular Center, Far Eastern Memorial Hospital, Taipei, Taiwan via Siemens AG.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.